Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NEZJ | ISIN: FR0010478248 | Ticker-Symbol: IFGA
Tradegate
17.01.25
20:35 Uhr
0,119 Euro
+0,002
+1,72 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
ATARI SA Chart 1 Jahr
5-Tage-Chart
ATARI SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,1160,11922:02
0,1160,11920:36
GlobeNewswire (Europe)
57 Leser
Artikel bewerten:
(0)

Atari Inc.: Atari Gives End-of-Year 2024 Business Update

Finanznachrichten News

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Atari® - one of the world's most iconic consumer brands and interactive entertainment producers - has today announced that its first full calendar year executing upon the company's retro-focused strategy has culminated in successful console and PC releases of Mighty Morphin Power Rangers: Rita's Rewind and The Thing: Remastered, as well as the Nintendo Switch release of RollerCoaster Tycoon Classic. The three titles exemplify Atari's belief that games based on high-quality, highly recognizable IPs can succeed in the crowded market for new video games.

Mighty Morphin Power Rangers: Rita's Rewind reached the number three spot among the best-selling digital titles on the Nintendo eShop, with RollerCoaster Tycoon Classic breaking into the top 15. The Thing: Remastered was well-received by critics and players alike and became Nightdive Studios' fastest-selling title at launch across all digital PC and console storefronts.

In addition, the company began shipping the Atari 7800+ retro console on November 29, fulfilling preorders and hitting the peak holiday shopping window. The 7800+, which uses HDMI and wireless controllers to marry retro aesthetics with modern living rooms, follows the company's very successful release of the 2600+ console, which re-introduced cartridge-based gaming.

In 2023, Atari committed to a strategic decision to refocus the game and hardware lines of business on the company's core strength in classic gaming. The 2023 acquisitions of game development studios Digital Eclipse and Nightdive Studios significantly deepened the company's expertise in bringing retro games from the 1970s through the early 2000s to modern PCs and consoles and expanded the company's skill and reputation for acquiring the rights to and developing content around some of the world's most beloved IPs.

In 2024, Nightdive Studios had major releases with Star Wars: Dark Forces Remaster and The Thing: Remastered; it also brought the 2023 PC hit System Shock to PlayStation and Xbox consoles. Digital Eclipse added two new installments to the studio's Gold Master series: Llamasoft: The Jeff Minter Story and Tetris Forever. The November release of Atari 50: The Anniversary Celebration Extended Edition to digital and physical storefronts extended the Digital Eclipse's success with playable documentaries, and the December release of Mighty Morphin Power Rangers: Rita's Rewind solidified the studio's reputation for doing justice to revered IP.

More than a half-dozen titles were also released under the Atari brand, including Yars Rising, a title developed by studio Wayforward based on one of Atari's most well-known 2600 games. Major distribution developments at Atari included the launch of a dedicated version of RollerCoaster Tycoon Touch for Netflix Mobile Games and the company's Recharged series of games for Netflix's new cloud gaming service. During the year, Atari also acquired the Intellivision brand and a large portfolio of Intellivision games, as well as RollerCoaster Tycoon 3, a perennial performer on PC and console.

Atari expanded its publishing footprint in April 2024 when it announced it was re-establishing a publishing label under the Infogrames brand. Infogrames has already acquired the publishing rights to a number of game franchises, including Bread and Fred, Totally Reliable Distribution Service, and Surgeon Simulator.

Wade Rosen, Chairman and Chief Executive Officer, commented: "It was critical that Atari execute against our retro-focused strategy in 2024, and I am extremely pleased with the company's performance across all of our business lines," said Wade Rosen, Chairman and CEO of Atari. "Ending the year with such a strong reception to our fourth-quarter game releases - Mighty Morphin Power Rangers: Rita's Rewind and The Thing: Remastered, as well as the Nintendo Switch release of RollerCoaster Tycoon Classic - gives me confidence that our strategy will lead to even more success in the coming year."

About Atari

Atari is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment, and licensed products. Atari owns and/or manages a portfolio of more than 200 unique games and franchises, including world-renowned brands like Asteroids®, Centipede®, Missile Command®, Pong®, and RollerCoaster Tycoon®. The Atari family of brands includes game developers Digital Eclipse and Nightdive Studios, the publishing label Infogrames, and the community-based sites AtariAge and MobyGames. Atari has offices in New York and Paris. Visit us online at www.Atari.com.

Atari shares are listed in France on Euronext Growth Paris (ISIN Code FR0010478248, Ticker ALATA) and OTC Pink Current (Ticker PONGF).

©2025 Atari Interactive, Inc. Atari wordmark and logo are trademarks owned by Atari Interactive, Inc.

PRESS CONTACT

Ron Burgess, CJ Melendez, Tabitha Beidleman, and Jordanne Laurito
ÜberStrategist Inc.
pr@uberstrategist.com
1-646-844-8388


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.